US Patent 11964961 Heteroaromatic compounds and their use as dopamine D1 ligands
Patent 11964961 was granted and assigned to Pfizer on April, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+43 properties)
US Patent 11964961 Heteroaromatic compounds and their use as dopamine D1 ligands
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Amy Beth Dounay0
Bruce Nelsen Rogers0
Chewah Lee0
David Lawrence Firman Gray0
Ivan Viktorovich Efremov0
Jaclyn Louise Henderson0
Jennifer Elizabeth Davoren0
Lei Zhang0
Michael Aaron Brodney0
Michael Eric Green0
Scot Richard Mente0
Steven Victor O'Neil0
Date of Patent
April 23, 2024
0Patent Application Number
172040950
Date Filed
March 17, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11964961 Heteroaromatic compounds and their use as dopamine D1 ligands
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.